Principales conclusions et analyse des parts de marché des inhibiteurs de la neuraminidase d'ici 2025-2031
Neuraminidase Inhibitors Drug Market Report Analysis
Neuraminidase Inhibitors Drug Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GLAXOSMITHKLINE PLC
- GILEAD SCIENCES
- DAIICHI SANKYO
- BIOCRYST LTD
- F. HOFFMANN LA ROCHE
- FOREST PHARMACEUTICALS INC.
- ENDO PHARMACEUTICALS INC.
- BRITANNICA
- SHIONOGI CO
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type de médicament
- Oseltamivir
- Zanamivir
- Peramivir
- Laninamivir
By Voie d'administration
- parentérale
- nasale et orale
By Canal de distribution
- pharmacie hospitalière
- pharmacie de détail
- pharmacie en ligne
- autre
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For